Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN (®) (dendritic cell‐based vaccine): a case report

APCEDEN (®) is an autologous monocyte‐derived dendritic cell‐based immunotherapy. A 58‐year‐old man with adenocarcinoma of oropharynx shows complete remission after receiving APCEDEN (®) in conjunction with Geftinib validated by reduction in size, whereas Gefitinib alone lead to disease progression....

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Chaitanya, Kohli, Sakshi, Chiliveru, Srikanth, Jain, Minish, Sharan, Bandana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628247/
https://www.ncbi.nlm.nih.gov/pubmed/29026574
http://dx.doi.org/10.1002/ccr3.1169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628247/
https://www.ncbi.nlm.nih.gov/pubmed/29026574
http://dx.doi.org/10.1002/ccr3.1169

Ejemplares similares